top of page

SEFAM Solutions

We can work with you and your team to develop tailored solutions to address current problems such as long waiting times, CPAP/APAP device shortages, mask supply and other consumables. 

The Sefam S.Box CPAP/APAP device and S.Box Duo S and ST Bilevel devices are the next step in advanced e-health technology, supporting personalised sleep medicine solutions and supporting the patient to be the owner of their treatment.

Out of stock.png
Is your service having problems accessing CPAP/APAP devices?

The Sefam S.Box is available via the national procurement process in the UK NHS, and you can also get access to the S.Box by contacting Sefam UK directly.

The Sefam S.Box Duo S and ST are available by contacting Sefam UK directly.

The Sefam UK team can arrange to visit your Sleep medicine department and speak to your team to demonstrate the S.Box hardware, its cloud-based Sefam Connect software and Sefam Analyse desktop software, and the Sefam Access patient and clinician Apps.

Modern Watch
Long waiting times for screening and diagnosis and treatment of OSA

The ever-increasing demand for OSAHS home sleep apnoea screening and diagnostic tests (HSAT) and treatment options has exceeded the capacity of sleep medicine services across the UK. 

 

There is a significant backlog for HSAT's with waits of up to two years or longer in some services which have been compounded by the SARSCoV2 pandemic. 

 

This necessitated cessation or reduction in diagnostic tests in many sleep services in the UK during the pandemic and services are still working to remobilise and deal with the backlog of referrals for sleep studies.

Long waits for an appropriate screening or diagnostic test following referral to a sleep medicine clinician are not acceptable for policymakers, healthcare services, and most of all for patients who may have an associated significant health burden such as excessive daytime sleepiness with an increased risk of workplace and motor vehicle accidents while they wait on a test.

There are a number screening of diagnostic sleep tests that range from in-lab full polysomnography testing, in-home polysomnography testing, and HSAT options that use polygraphy and other methods such as the Sunrise device.  The sleep medicine clinician will decide what is the most suitable test following referral.

New technology-enabled care solutions have a place in the diagnostic testing pathway and this is where Sefam UK can provide a unique solution to assist with reducing waiting times and prioritise those patients that may be suitable for a simple HSAT.

This can be managed with less clinician contact and the option of the delivery of more remote care solutions which can be time saving for services. Patients with negative HSATs may then be screened out of the pathway freeing up staff time to increase capacity to reduce waiting list times.  

 

Sunrise 

The Sunrise device is a 3 g sensor that is attached to the chin during the night (with an adhesive film) that can be used to screen for the presence of OSA. 

 

It works by measuring mandibular movements during sleep and  uses artificial intelligence and machine learning to screen for sleep disordered breathing.

Personalising CPAP/APAP Therapy

A personalised  approach in the care of people with OAHS  is  important in the co-management of people living with this common condition.

So how can the Sefam S.Box and S.Box Duo and their connected devices, software, and patient and clinician apps contribute to a more personalised approach to holistic OSA care?

  • As there is not one profile that suits all CPAP patients, we believe patients need to be treated individually to achieve better care outcomes.

  • The S.Box options are much more than a treatment device, they incorporate an innovative ecosystem that puts the patients at the centre of their treatment.

  • In addition to the innovations of the Auto-CPAP device, the Sefam S.Box concept offers a patient mobile app  (Sefam Access Lite) and compatible connected devices.

  • These connected devices provide not only day-to-day treatment efficacy data but can also monitor also other important patient-specific physiological parameters such as:

    • Heart rate

    • Blood pressure

    • Physical activity

  • Oxygen saturation

  • Weight

Screenshot 2022-07-03 11.42.54.png
Assessing Treatment Efficacy

The user friendly  Sefam Analyse desktop software allows clinicians to have an in-depth look at treatment efficacy including oximetry recordings with a on treatment sleep study via the PolyLink system.

The PolyLink  allows the acquisition of signals during therapy:

  • Oxygen saturation

  • Heart rate

  • Snoring/flow limitation

  • Respiratory effort

  • mask leak

  • Pressure delivery

  • Chest and abdominal movements

  • Body position

PolyLink, in combination with the S.Box device, allows Polygraphic control of treatment effectiveness as well as home titration under polygraphy.

Another unique feature of the Sefam Analyse software is that PolyLink data can be viewed in the same software.

application-sefam-access-visuel-main-EN copie.jpg
Patient Engagement

The Sefam Access Lite patient app works on both IOS and android devices.  It can be paired with your device using a Wi-Fi network or GPS network.

The patient can then monitor their therapy efficacy in terms of the mask on time, mask leaks, and  if their sleep apnoea is being adequately controlled.

Also unique to the Sefam S.Box is the ability to connect:

  • weighing scales - if weight reduction is also prescribed as part of the personalised treatment plan

  • An activity tracker can also be connected if exercise has also been prescribed as part of the treatment plan

  • A wireless Blood pressure monitor can also be connected if the clinician wishes to monitor the effect of commencing CPAP therapy on any reduction in blood pressure before considering commencing oral antihypertensive therapy.

So in summary the Sefam S.Box can provide not only CPAP/APAP/Bilevel therapy and remote monitoring of adherence but also a much more personalised approach to the co-management of this condition and the causes and consequences of OSA.

bottom of page